Furthermore, SELENOF overexpression attenuates a number of aggressive cancer phenotypes in breast cancer cells, including clonogenic survival and mammosphere formation, and enhances the response to drugs or radiation used in breast cancer therapy. This evidence concerns the gene SELENOF and breast cancer.